YOLO is among the first ETFs with a dedicated exposure to cannabis. This actively-managed fund primarily invests in mid- and small-cap global companies that derive at least 50% of their net revenue from the marijuana and hemp industry. The fund also invests in total return swaps of securities with similar characteristics. It may also invest in companies that are registered with the DEA specifically to use marijuana for lawful research and development of cannabis or cannabinoid-related products. The fund adviser seeks companies that hold dominant positions in their respective markets or those with a unique opportunity for growth and expansion. Although cannabis stocks may be categorized among a wide variety of sectors and industries, the fund has a health care sector tilt, concentrating at least 25% of its assets in pharmaceuticals, biotechnology and life sciences.